Composition : Pitavastatin 2mg + Fenofibrate 67.5mg
Form : Tablets
/
Pack : 10’s
/
Type : ALU-ALU
Description : Co-administration of pitavastatin and fenofibrate should be considered as one of the options for the treatment of hypercholestrolemic patients with hupertriglyceridemia, in whom, control of the lipid profile sometimes becomes problematic in routine clinical practice -
Japanese Clincal Medicine 2011:2 57-66
Pitvastatin and atorvastatin cuased significant and almost comparable reductions in serum levels of total cholesterol (-35.4 vs -33.8%), low-density lipoprotein cholesterol (-42.8 vs.-40.7%), and triglyceride (-26.1 vs -29.4%) and significantly increased serum levels of high-density lipoprotein cholesterol (12.1 vs 11.4%). Under these conditions, plasma levels of CoQ10 were reduced by atorvastatin (-26.1%, P=0.0007) but not by pitavastatin (-7.7%, P=0.39) -
Clin Pharmacol Ther, 2008 May;83(5):731-9
View more products with following salts
Fenofibrate Pitavastatin